SEC Form 10-Q filed by Emerson Electric Company

8/7/24 6:58:45 AM ET

$EMR

Consumer Electronics/Appliances

Technology

Get the next $EMR alert in real time by email

emr-20240630

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

______________________

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES

EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2024

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES

EXCHANGE ACT OF 1934

For the transition period from ____________________ to __________________

Commission file number 1-278

EMERSON ELECTRIC CO.

(Exact name of registrant as specified in its charter)


Missouri		43-0259330
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

8000 W. Florissant Ave.
P.O. Box 4100
St. Louis,	Missouri	63136
(Address of principal executive offices)		(Zip Code)

Registrant's telephone number, including area code: (314) 553-2000

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock of $0.50 par value per share	EMR	New York Stock Exchange
		NYSE Chicago

1.250% Notes due 2025	EMR 25A	New York Stock Exchange
2.000% Notes due 2029	EMR 29	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☒

Accelerated filer

☐

Non-accelerated filer

☐

Smaller reporting company

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date. Common stock of $0.50 par value per share outstanding at June 30, 2024: 572.7 million shares.

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

Consolidated Statements of Earnings

EMERSON ELECTRIC CO. & SUBSIDIARIES

Three and nine months ended June 30, 2023 and 2024

(Dollars in millions, except per share amounts; unaudited)


	Three Months Ended June 30,			Nine Months Ended June 30,
	2023		2024	2023	2024
Net sales	$	3,946	4,380	11,075	12,873

Cost of sales	1,952		2,066	5,660	6,359
Selling, general and administrative expenses	1,042		1,254	3,072	3,827
Gain on subordinated interest	—		—	—	(79)
Loss on Copeland note receivable	—		279	—	279
Other deductions, net	130		294	359	1,075
Interest expense (net of interest income of $58, $32, $96 and $105, respectively)	10		56	111	157
Interest income from related party	(10)		(24)	(10)	(86)

Earnings from continuing operations before income taxes	822		455	1,883	1,341

Income taxes	168		88	400	266

Earnings from continuing operations	654		367	1,483	1,075

Discontinued operations, net of tax of $2,004, $5, $3,009 and $27, respectively	8,712		(15)	10,979	(88)

Net earnings	9,366		352	12,462	987

Less: Noncontrolling interests in subsidiaries	14		23	(13)	15

Net earnings common stockholders	$	9,352	329	12,475	972

Earnings common stockholders:
Earnings from continuing operations	643		344	1,502	1,060
Discontinued operations	8,709		(15)	10,973	(88)
Net earnings common stockholders	$	9,352	329	12,475	972

Basic earnings per share common stockholders:
Earnings from continuing operations	$	1.12	0.60	2.61	1.85
Discontinued operations	15.24		(0.02)	19.06	(0.15)
Basic earnings per common share	$	16.36	0.58	21.67	1.70

Diluted earnings per share common stockholders:
Earnings from continuing operations	$	1.12	0.60	2.60	1.84
Discontinued operations	15.16		(0.03)	18.96	(0.15)
Diluted earnings per common share	$	16.28	0.57	21.56	1.69

Weighted average outstanding shares:
Basic	570.9		571.9	575.1	571.4
Diluted	574.0		574.8	578.1	574.1

See accompanying Notes to Consolidated Financial Statements.

Consolidated Statements of Comprehensive Income

EMERSON ELECTRIC CO. & SUBSIDIARIES

Three and nine months ended June 30, 2023 and 2024

(Dollars in millions; unaudited)


	Three Months Ended June 30,			Nine Months Ended June 30,
	2023		2024	2023	2024
Net earnings	$	9,366	352	12,462	987

Other comprehensive income (loss), net of tax:
Foreign currency translation	86		(124)	437	56
Pension and postretirement	10		(12)	(23)	(36)
Cash flow hedges	(19)		(6)	4	(4)
Total other comprehensive income (loss)	77		(142)	418	16

Comprehensive income	9,443		210	12,880	1,003

Less: Noncontrolling interests in subsidiaries	15		21	(8)	15
Comprehensive income common stockholders	$	9,428	189	12,888	988

See accompanying Notes to Consolidated Financial Statements.

Consolidated Balance Sheets

EMERSON ELECTRIC CO. & SUBSIDIARIES

(Dollars and shares in millions, except per share amounts; unaudited)


	Sept 30, 2023		June 30, 2024
ASSETS
Current assets
Cash and equivalents	$	8,051	2,298
Receivables, less allowances of $100 and $115, respectively	2,518		2,761
Inventories	2,006		2,303
Other current assets	1,244		1,458
Total current assets	13,819		8,820

Property, plant and equipment, net	2,363		2,688
Other assets
Goodwill	14,480		17,936
Other intangible assets	6,263		10,627
Copeland note receivable and equity investment held-for-sale	3,255		2,908
Other	2,566		2,606
Total other assets	26,564		34,077
Total assets	$	42,746	45,585

LIABILITIES AND EQUITY
Current liabilities
Short-term borrowings and current maturities of long-term debt	$	547	2,991
Accounts payable	1,275		1,251
Accrued expenses	3,210		3,350
Total current liabilities	5,032		7,592

Long-term debt	7,610		7,111

Other liabilities	3,506		4,194

Equity
Common stock, $0.50 par value; authorized, 1,200.0 shares; issued, 953.4 shares; outstanding, 572.0 shares and 572.7 shares, respectively	477		477
Additional paid-in-capital	62		140
Retained earnings	40,070		40,135
Accumulated other comprehensive income (loss)	(1,253)		(1,237)
Cost of common stock in treasury, 381.4 shares and 380.7 shares, respectively	(18,667)		(18,716)
Common stockholders’ equity	20,689		20,799
Noncontrolling interests in subsidiaries	5,909		5,889
Total equity	26,598		26,688
Total liabilities and equity	$	42,746	45,585

See accompanying Notes to Consolidated Financial Statements.

Consolidated Statements of Equity

EMERSON ELECTRIC CO. & SUBSIDIARIES

Three and nine months ended June 30, 2023 and 2024

(Dollars in millions; unaudited)


	Three Months Ended June 30,			Nine Months Ended June 30,
	2023		2024	2023	2024

Common stock	$	477	477	477	477

Additional paid-in-capital
Beginning balance	138		158	57	62
Stock plans	30		16	111	186
AspenTech purchases of common stock	(56)		(34)	(56)	(108)
Ending balance	112		140	112	140

Retained earnings
Beginning balance	30,571		40,108	28,053	40,070
Net earnings common stockholders	9,352		329	12,475	972
Dividends paid (per share: $0.52, $0.525, $1.56 and $1.575, respectively)	(299)		(302)	(904)	(907)
Ending balance	39,624		40,135	39,624	40,135

Accumulated other comprehensive income (loss)
Beginning balance	(1,148)		(1,097)	(1,485)	(1,253)
Foreign currency translation	85		(122)	432	56
Pension and postretirement	10		(12)	(23)	(36)
Cash flow hedges	(19)		(6)	4	(4)
Ending balance	(1,072)		(1,237)	(1,072)	(1,237)

Treasury stock
Beginning balance	(18,678)		(18,746)	(16,738)	(18,667)
Purchases	—		—	(2,000)	(175)
Issued under stock plans	1		30	61	126
Ending balance	(18,677)		(18,716)	(18,677)	(18,716)

Common stockholders' equity	20,464		20,799	20,464	20,799

Noncontrolling interests in subsidiaries
Beginning balance	5,987		5,881	5,952	5,909
Net earnings (loss)	14		23	(13)	15
Stock plans	21		15	79	48
AspenTech purchases of common stock	(44)		(25)	(44)	(80)
Dividends paid	(1)		(3)	(1)	(3)
Climate Technologies divestiture	(29)		—	(29)	—
Other comprehensive income	1		(2)	5	—
Ending balance	5,949		5,889	5,949	5,889

Total equity	$	26,413	26,688	26,413	26,688

See accompanying Notes to Consolidated Financial Statements.

Consolidated Statements of Cash Flows

EMERSON ELECTRIC CO. & SUBSIDIARIES

Nine Months Ended June 30, 2023 and 2024

(Dollars in millions; unaudited)


	Nine Months Ended
	June 30,
	2023		2024
Operating activities
Net earnings	$	12,462	987
Earnings from discontinued operations, net of tax	(10,979)		88
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	780		1,263
Stock compensation	198		203
Amortization of acquisition-related inventory step-up	—		231
Gain on subordinated interest	—		(79)
Changes in operating working capital	(359)		(176)
Loss on Copeland note receivable	—		279
Other, net	(383)		(552)
Cash from continuing operations	1,719		2,244
Cash from discontinued operations	(439)		4
Cash provided by operating activities	1,280		2,248

Investing activities
Capital expenditures	(194)		(251)
Purchases of businesses, net of cash and equivalents acquired	—		(8,342)
Proceeds from subordinated interest	15		79
Proceeds from related party note receivable	918		—
Other, net	(124)		(86)
Cash from continuing operations	615		(8,600)
Cash from discontinued operations	12,485		36
Cash provided by (used in) investing activities	13,100		(8,564)

Financing activities
Net increase (decrease) in short-term borrowings	(1,476)		2,229
Proceeds from short-term borrowings greater than three months	395		322
Payments of short-term borrowings greater than three months	(400)		(100)
Payments of long-term debt	(744)		(547)
Dividends paid	(900)		(901)
Purchases of common stock	(2,000)		(175)
AspenTech purchases of common stock	(100)		(188)
Payment of related party note payable	(918)		—
Other, net	(159)		(57)
Cash provided by (used in) financing activities	(6,302)		583

Effect of exchange rate changes on cash and equivalents	75		(20)
Increase (decrease) in cash and equivalents	8,153		(5,753)
Beginning cash and equivalents	1,804		8,051
Ending cash and equivalents	$	9,957	2,298

Changes in operating working capital
Receivables	$	(114)	44
Inventories	(259)		(34)
Other current assets	27		(130)
Accounts payable	(71)		(61)
Accrued expenses	58		5
Total changes in operating working capital	$	(359)	(176)

See accompanying Notes to Consolidated Financial Statements.

Notes to Consolidated Financial Statements

EMERSON ELECTRIC CO. & SUBSIDIARIES

(Dollars and shares in millions, except per share amounts or where noted)

(1) BASIS OF PRESENTATION

In the opinion of management, the accompanying unaudited consolidated financial statements include all adjustments necessary for a fair presentation of operating results for the interim periods presented. Adjustments consist of normal and recurring accruals. The consolidated financial statements are presented in accordance with the requirements of Form 10-Q and consequently do not include all disclosures required for annual financial statements presented in conformity with U.S. generally accepted accounting principles (GAAP). For further information, refer to the consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended September 30, 2023.

Certain prior year amounts have been reclassified to conform to the current year presentation. On June 6, 2024, the Company entered into definitive agreements to sell its 40 percent non-controlling common equity interest in Copeland to private equity funds managed by Blackstone for $1.5 billion and its note receivable to Copeland for $1.9 billion. As a result of the definitive agreements, the equity interest and note receivable are reported as held-for-sale, and the equity method losses related to the Company's non-controlling common equity interest in Copeland, which were reported since May 2023 in Other deductions, net, have been reclassified and are now reported as discontinued operations for all periods presented (see Notes 5 and 10).

(2) REVENUE RECOGNITION

Emerson is a global manufacturer that designs and manufactures products and delivers services that bring technology and engineering together to provide innovative solutions for its customers. The majority of the Company's revenues relate to a broad offering of manufactured products and software which are recognized at the point in time when control transfers, while a smaller portion is recognized over time or relates to sales arrangements with multiple performance obligations. See Note 14 for additional information about the Company's revenues.

The following table summarizes the balances of the Company's unbilled receivables (contract assets), which are reported in Other assets (current and noncurrent), and its customer advances (contract liabilities), which are reported in Accrued expenses and Other liabilities.


	Sept 30, 2023			June 30, 2024
Unbilled receivables (contract assets)		$	1,453		1,541
Customer advances (contract liabilities)		(897)			(1,158)
Net contract assets (liabilities)		$	556		383

The majority of the Company's contract balances relate to (1) arrangements where revenue is recognized over time and payments from customers are made according to a contractual billing schedule, and (2) revenue from term software license arrangements where the license revenue is recognized upfront upon delivery. The decrease in net contract assets was primarily due to the acquisition of National Instruments, which increased contract liabilities by approximately $160, while customer billings slightly exceeded revenue recognized for performance completed during the period. Revenue recognized for the three and nine months ended June 30, 2024 included $83 and $605, respectively, that was included in the beginning contract liability balance. Other factors that impacted the change in net contract assets were immaterial. Revenue recognized for the three and nine months ended June 30, 2024 for performance obligations that were satisfied in previous periods, including cumulative catchup adjustments on the Company's long-term contracts, was immaterial.

As of June 30, 2024, the Company's backlog relating to unsatisfied (or partially unsatisfied) performance obligations in contracts with its customers was approximately $8.7 billion (of which approximately $1.3 billion was attributable to AspenTech and approximately $450 was attributable to National Instruments). The Company expects to recognize approximately 75 percent of its remaining performance obligations as revenue over the next 12 months, with the remainder substantially over the following two years.

(3) COMMON SHARES

Reconciliations of weighted-average shares for basic and diluted earnings per common share follow. Earnings allocated to participating securities were inconsequential.


	Three Months Ended June 30,		Nine Months Ended June 30,
	2023	2024	2023	2024

Basic shares outstanding	570.9	571.9	575.1	571.4
Dilutive shares	3.1	2.9	3.0	2.7
Diluted shares outstanding	574.0	574.8	578.1	574.1

(4) ACQUISITIONS AND DIVESTITURES

National Instruments

On October 11, 2023, the Company completed the acquisition of National Instruments Corporation (“NI”). NI, which provides software-connected automated test and measurement systems that enable enterprises to bring products to market faster and at a lower cost, had revenues of approximately $1.7 billion and pretax earnings of approximately $170 for the 12 months ended September 30, 2023. NI is now referred to as Test & Measurement and reported as a new segment in the Software and Control business group, see Note 14.

The following table summarizes the components of the purchase consideration reflected in the acquisition accounting for NI.


Cash paid to acquire remaining NI shares not already owned by Emerson	$	7,833
Payoff of NI debt at closing	634
Total consideration paid in cash at closing	8,467
Fair value of NI shares already owned by Emerson prior to acquisition	137
Value of stock-based compensation awards attributable to pre-combination service	49
Total purchase consideration	$	8,653

The total purchase consideration for NI was allocated to assets and liabilities as follows. Valuations of acquired assets and liabilities are in-process and subject to refinement.


Cash and equivalents	$	135
Receivables	310
Inventory	496
Other current assets	140
Property, plant and equipment	329
Goodwill ($121 expected to be tax-deductible)	3,434
Other intangible assets	5,275
Other assets	113
Total assets	10,232

Accounts payable	52
Accrued expenses	328
Deferred taxes and other liabilities	1,199
Total purchase consideration	$	8,653

The estimated intangible assets attributable to the transaction are comprised of the following (in millions):


	Amount		Estimated Weighted Average Life (Years)
Developed technology	$	1,570	9
Customer relationships	3,360		15
Trade names	210		9
Backlog	135		1
Total	$	5,275

Results of operations for the three and nine months ended June 30, 2024 attributable to the NI acquisition include sales of $355 and $1,104, respectively, and a net loss of $86 and $492, respectively. The net loss included the impact of inventory step-up amortization recorded in the first quarter, intangibles amortization, retention bonuses, stock compensation expense and restructuring.

Pro Forma Financial Information

The following unaudited proforma consolidated condensed financial results of operations are presented as if the acquisition of NI occurred on October 1, 2022. The pro forma information is presented for informational purposes only and is not indicative of the results of operations that would have been achieved had the acquisition occurred as of that time ($ in millions, except per share amounts).


	Three Months Ended June 30,			Nine Months Ended June 30,
	2023		2024	2023	2024
Net Sales	$	4,363	4,380	12,377	12,892
Net earnings from continuing operations common stockholders	$	581	374	887	1,396
Diluted earnings per share from continuing operations	$	1.00	0.65	1.53	2.43

Pro forma Net sales for the three and nine months ended June 30, 2023 include $417 and $1,302, respectively, attributable to NI.

The pro forma results for the three months ended June 30, 2023 include ongoing intangibles amortization of $105 and backlog amortization of $34, and exclude the mark-to-market gain of $12 recognized in the prior year on the Company's equity investment in National Instruments Corporation (see Note 7).

The pro forma results for the nine months ended June 30, 2023 include transaction costs of $198 which were assumed to be incurred in the first quarter of fiscal 2023. These transaction costs include $88 incurred by NI prior to the completion of the transaction and $110 incurred by Emerson in periods subsequent to the first quarter of fiscal 2023. The pro forma results for the nine months ended June 30, 2023 also include $317 of ongoing intangibles amortization, backlog amortization of $102, inventory step-up amortization of $213, and retention bonuses of $51, and exclude the mark-to-market gain of $47 recognized in the prior year on the equity investment in National Instruments Corporation.

Other Transactions

In the second quarter of fiscal 2024, the Company received its final distribution of $79 related to its subordinated interest in Vertiv. In addition, the Company divested a small business in the Final Control segment and recognized a non-cash loss of $39.

In the fourth quarter of fiscal 2023, the Company acquired two businesses, Flexim, which is reported in the Measurement & Analytical segment, and Afag, which is reported in the Discrete Automation segment, for $715, net of cash acquired. The Company recognized goodwill of $424 (none of which is expected to be tax deductible) and other identifiable intangible assets of $323, primarily customer relationships and intellectual property with a weighted-average useful life of approximately 9 years.

On March 31, 2023, Emerson completed the divestiture of Metran, its Russia-based manufacturing subsidiary. In the first quarter of fiscal 2023, the Company recognized a pretax loss of $47 in Other deductions ($47 after-tax, in total $0.08 per share) related to its exit of business operations in Russia.

(5) DISCONTINUED OPERATIONS

On May 31, 2023, the Company completed the sale of a majority stake in its Climate Technologies business (which constitutes the former Climate Technologies segment, excluding Therm-O-Disc which was divested earlier in fiscal 2022) to private equity funds managed by Blackstone in a $14.0 billion transaction. Emerson received upfront, pretax cash proceeds of approximately $9.7 billion and a note receivable with a face value of $2.25 billion (which accrues 5 percent interest payable in kind by capitalizing interest), while retaining a 40 percent non-controlling common equity interest in a new standalone joint venture between Emerson and Blackstone. The Climate Technologies business, which includes the Copeland compressor business and the entire portfolio of products and services across all residential and commercial HVAC and refrigeration end-markets, had fiscal 2022 net sales of approximately $5.0 billion and pretax earnings of $1.0 billion. The Company recognized a pretax gain of approximately $10.6 billion in the third quarter of fiscal 2023 (approximately $8.4 billion after-tax including tax expense recognized prior to the completion of the transaction related to subsidiary restructurings). The new standalone business is named Copeland.

On June 6, 2024, the Company entered into a definitive agreement to sell its 40 percent non-controlling common equity interest in Copeland to private equity funds managed by Blackstone for $1.5 billion, and the transaction is expected to close by the end of August 2024. The equity method losses related to the Company's non-controlling common equity interest in Copeland, which were reported since May 2023 in Other deductions, net, have been reclassified and are now reported as discontinued operations for all periods presented and are included within Climate Technologies in Other deductions, net in the tables below. See Note 10 for further details.

On October 31, 2022, the Company completed the divestiture of its InSinkErator business, which manufactures food waste disposers, to Whirlpool Corporation for $3.0 billion. This business had net sales of $630 and pretax earnings of $152 in fiscal 2022. The Company recognized a pretax gain of approximately $2.8 billion (approximately $2.1 billion after-tax) in the first quarter of fiscal 2023.

For the three and nine months ended June 30, 2024, the results of discontinued operations primarily reflect the Company's equity method losses on its non-controlling common equity interest in Copeland, which were $16 ($9 after-tax) and $111 ($82 after-tax), respectively. For the three and nine months ended June 30, 2023, the financial results of Climate Technologies (including equity method losses on the equity interest in Copeland) and InSinkErator ("ISE") are reported as discontinued operations and were as follows:


	Three Months Ended June 30, 2023
	Climate Technologies		ISE	Total
Net sales	$	847	—	847
Cost of sales	516		—	516
SG&A	122		—	122
Gain on sale of business	(10,576)		—	(10,576)
Other deductions, net	69		—	69
Earnings before income taxes	10,716		—	10,716
Income taxes	2,004		—	2,004
Earnings, net of tax	$	8,712	—	8,712

	Nine Months Ended June 30, 2023
	Climate Technologies		ISE	Total
Net sales	$	3,156	49	3,205
Cost of sales	2,000		29	2,029
SG&A	391		8	399
Gain on sale of business	(10,576)		(2,783)	(13,359)
Other deductions, net	136		12	148
Earnings before income taxes	11,205		2,783	13,988
Income taxes	2,356		653	3,009
Earnings, net of tax	$	8,849	2,130	10,979

Climate Technologies' results for the three and nine months ended June 30, 2023 included lower expense of $26 and $96, respectively, due to ceasing depreciation and amortization upon the held-for-sale classification. Other deductions, net for Climate Technologies included $57 of transaction-related costs for the nine months ended June 30, 2023. For the three and nine months ended June 30, 2023, the Company recorded a loss of $61 in Other deductions, net to reflect equity method losses on its non-controlling common equity interest in Copeland. Income taxes for the three and nine months ended June 30, 2023 included a tax benefit of $10 related to Copeland's U.S. business, which is taxed as a partnership. Income taxes for the nine months ended June 30, 2023 included approximately $2.2 billion for the gain on the Climate Technologies subsidiary restructurings and approximately $660 related to the gain on the InSinkErator divestiture.

Net cash from operating and investing activities for Climate Technologies, InSinkErator and Therm-O-Disc for the nine months ended June 30, 2024 and 2023 were as follows:


	Climate Technologies				ISE and TOD				Total
	Nine Months Ended June 30,				Nine Months Ended June 30,			Nine Months Ended June 30,
		2023		2024		2023	2024		2023	2024
Cash from operating activities		$	156	4		(595)	—		(439)	4
Cash from investing activities		$	9,430	36		3,055	—		12,485	36

Cash from operating activities for the nine months ended June 30, 2023 reflects approximately $750 of income taxes paid related to the gain on the InSinkErator divestiture and the Climate Technologies subsidiary restructurings,

transaction fees and unfavorable working capital. Cash from investing activities for the nine months ended June 30, 2023 reflects the proceeds of approximately $9.7 billion related to the Copeland transaction and approximately $3.0 billion related to the InSinkErator divestiture.

(6) PENSION & POSTRETIREMENT PLANS

Total periodic pension and postretirement (income) expense is summarized below:


	Three Months Ended June 30,				Nine Months Ended June 30,
		2023		2024		2023	2024
Service cost		$	12	9		36	27
Interest cost		54		55		162	165
Expected return on plan assets		(71)		(74)		(213)	(222)
Net amortization		(18)		(14)		(58)	(42)
Total		$	(23)	(24)		(73)	(72)

(7) OTHER DEDUCTIONS, NET

Other deductions, net are summarized below:


	Three Months Ended June 30,				Nine Months Ended June 30,
	2023			2024		2023	2024

Amortization of intangibles (intellectual property and customer relationships)		$	120	264		357	811
Restructuring costs		12		57		41	170
Acquisition/divestiture costs		38		7		48	92
Foreign currency transaction (gains) losses		22		9		41	60
Investment-related gains & gains from sales of capital assets		(26)		—		(63)	—
Loss on divestiture of business		—		—		—	39
Russia business exit		—		—		47	—
Other		(36)		(43)		(112)	(97)
Total		$	130	294		359	1,075

Intangibles amortization for the three and nine months ended June 30, 2024 included $139 and $419, respectively, related to the NI acquisition. Foreign currency transaction losses for the three and nine months ended June 30, 2023 included a mark-to-market gain of $3 and $24, respectively, related to foreign currency forward contracts that were terminated in June 2023. The Company recognized a mark-to-market gain of $12 and $47 for the three and nine months ended June 30, 2023, respectively, related to its equity investment in National Instruments Corporation. Other is composed of several items, including a portion of pension expense, litigation costs, provision for bad debt and other items, none of which is individually significant.

(8) RESTRUCTURING COSTS

Restructuring expense reflects costs associated with the Company’s ongoing efforts to improve operational efficiency and deploy assets globally in order to remain competitive on a worldwide basis. The Company expects fiscal 2024 restructuring expense and related costs to be approximately $250, including costs to complete actions initiated in the first nine months of the year.

Restructuring expense by business segment follows:


	Three Months Ended June 30,					Nine Months Ended June 30,
	2023			2024		2023		2024

Final Control		$	(2)		5		(1)		1
Measurement & Analytical		1			3		2		7
Discrete Automation		12			16		20		33
Safety & Productivity		(1)			1		1		2
Intelligent Devices		10			25		22		43

Control Systems & Software		1			3		7		7
Test & Measurement		—			24		—		78
AspenTech		—			—		—		—
Software and Control		1			27		7		85

Corporate		1			5		12		42

Total		$	12		57		41		170

Corporate restructuring of $5 and $42 for the three and nine months ended June 30, 2024, respectively, is comprised almost entirely of integration-related stock compensation expense attributable to NI.

Details of the change in the liability for restructuring costs during the nine months ended June 30, 2024 follow:


	Sept 30, 2023			Expense		Utilized/Paid		June 30, 2024

Severance and benefits		$	85		142		129		98




Other		2			28		24		6
Total		$	87		170		153		104

The tables above do not include $1 and $3 of costs related to restructuring actions incurred for the three months ended June 30, 2023 and 2024, respectively, that are required to be reported in cost of sales and selling, general and administrative expenses; year-to-date amounts are $13 and $10, respectively.

(9) TAXES

Income taxes were $88 in the third quarter of fiscal 2024 and $168 in 2023, resulting in effective tax rates of 19 percent and 21 percent, respectively. The current year rate reflected a 3 percentage point benefit related to the filing of the prior year U.S. tax return, partially offset by other items.

Income taxes were $266 in the first nine of months of fiscal 2024 and $400 in 2023, resulting in effective tax rates of 20 percent and 21 percent, respectively. The current year rate included a $57 ($0.10 per share) benefit related to discrete tax items and the benefit discussed above related to the prior year U.S. tax return, partially offset by unfavorable impacts from inventory step-up amortization and the loss on divestiture (see Note 4), which was nondeductible for tax purposes. In total, the net impact of these items benefited the rate by approximately 2 percentage points, which was partially offset by other items.

(10) EQUITY METHOD INVESTMENT AND NOTE RECEIVABLE

As discussed in Note 5, the Company completed the divestiture of a majority stake in Copeland on May 31, 2023, and received upfront, pretax cash proceeds of approximately $9.7 billion and a note receivable with a face value of $2.25 billion, while retaining a 40 percent non-controlling common equity interest in Copeland.

On June 6, 2024, the Company entered into definitive agreements to sell its 40 percent non-controlling common equity interest in Copeland to private equity funds managed by Blackstone for $1.5 billion and the note receivable to Copeland for $1.9 billion. The equity interest and note receivable, as well as $33 of future indemnity obligations included in Other liabilities (net of tax), are reported as held-for-sale as of June 30, 2024. Subsequent to the end of the quarter, the Company completed the sale of the note receivable on August 2, 2024 and received $1.9 billion of pretax cash proceeds. The sale of the equity interest is expected to close by the end of August 2024.

The Company recognized non-cash interest income on the note receivable (through the date of the agreement) of $24 and $86 for the three and nine months ended June 30, 2024, respectively, which is reported in Interest income from related party within continuing operations and capitalized to the carrying value of the note. Upon entering into the note agreement, the Company recorded a pretax loss of $279 ($217 after-tax, $0.38 per share) to adjust the carrying value of the note to $1.9 billion to reflect the transaction price.

The Company's share of Copeland's income or loss, which will continue to be recorded using the equity method of accounting until the transaction is completed, is now reported in discontinued operations for all periods presented (see Note 5). As of June 30, 2024, the carrying value of the retained equity investment was $1,008. Summarized financial information for Copeland for the three and nine months ended June 30, 2024 is as follows.


	Three Months Ended June 30,		Nine Months Ended June 30,
	2024		2024
Net sales	$	1,259	$	3,458
Gross profit	$	441	$	1,198
Income (loss) from continuing operations	$	(40)	$	(280)
Net income (loss)	$	(40)	$	(280)
Net income (loss) attributable to shareholders	$	(40)	$	(278)

(11) OTHER FINANCIAL INFORMATION


	Sept 30, 2023			June 30, 2024
Inventories
Finished products		$	446		551
Raw materials and work in process		1,560			1,752
Total		$	2,006		2,303




Property, plant and equipment, net
Property, plant and equipment, at cost	$	5,524	5,994
Less: Accumulated depreciation	3,161		3,306
Total	$	2,363	2,688



	Sept 30, 2023		June 30, 2024
Goodwill by business segment
Final Control	$	2,660	2,668
Measurement & Analytical	1,545		1,548
Discrete Automation	892		899
Safety & Productivity	388		391
Intelligent Devices	5,485		5,506


Control Systems & Software	668		670
Test & Measurement	—		3,433
AspenTech	8,327		8,327
Software and Control	8,995		12,430

Total	$	14,480	17,936



Other intangible assets
Gross carrying amount	$	10,111	15,443
Less: Accumulated amortization	3,848		4,816
Net carrying amount	$	6,263	10,627

Other intangible assets include customer relationships, net, of $3,353 and $6,325 and intellectual property, net, of $2,707 and $4,067 as of September 30, 2023 and June 30, 2024, respectively.

The increase in goodwill and intangibles was primarily due to the NI acquisition. See Note 4.


	Three Months Ended June 30,			Nine Months Ended June 30,
	2023		2024	2023	2024
Depreciation and amortization expense include the following:
Depreciation expense	$	67	80	213	238
Amortization of intangibles (includes $49, $49, $147 and $147 reported in Cost of Sales, respectively)	169		313	504	958
Amortization of capitalized software	21		24	63	67
Total	$	257	417	780	1,263

Amortization of intangibles included $139 and $419 related to the NI acquisition for the three and nine months ended June 30, 2024.


	Sept 30, 2023			June 30, 2024
Other assets include the following:
Pension assets		$	995		1,070
Operating lease right-of-use assets		550			685
Unbilled receivables (contract assets)		559			515
Deferred income taxes		100			59
Asbestos-related insurance receivables		53			38


	Sept 30, 2023			June 30, 2024
Accrued expenses include the following:
Customer advances (contract liabilities)		$	861		1,088
Employee compensation		618			630
Income taxes		207			231
Operating lease liabilities (current)		144			153
Product warranty		84			74



Other liabilities include the following:
Deferred income taxes	$	1,959	2,507
Operating lease liabilities (noncurrent)	404		511
Pension and postretirement liabilities	435		443
Asbestos litigation	173		161

The increase in deferred income tax liabilities reflects the impact of the NI acquisition. See Note 4.

(12) FINANCIAL INSTRUMENTS

Hedging Activities – As of June 30, 2024, the notional amount of foreign currency hedge positions was approximately $3.1 billion. All derivatives receiving hedge accounting are cash flow hedges. The majority of hedging gains and losses deferred as of June 30, 2024 are expected to be recognized over the next 12 months as the underlying forecasted transactions occur. Gains and losses on foreign currency derivatives reported in Other deductions, net reflect hedges of balance sheet exposures that do not receive hedge accounting.

Net Investment Hedge – In fiscal 2019, the Company issued euro-denominated debt of €1.5 billion, of which €500 was repaid in the third quarter of fiscal 2024. The euro notes reduce foreign currency risk associated with the Company's international subsidiaries that use the euro as their functional currency and have been designated as a hedge of a portion of the investment in these operations. Foreign currency gains or losses associated with the euro-denominated debt are deferred in accumulated other comprehensive income (loss) and will remain until the hedged investment is sold or substantially liquidated.

The following gains and losses are included in earnings and other comprehensive income (OCI) for the three and nine months ended June 30, 2023 and 2024:


		Into Earnings					Into OCI
		3rd Quarter			Nine Months		3rd Quarter		Nine Months
Gains (Losses)	Location	2023		2024	2023	2024	2023	2024	2023	2024
Commodity	Cost of sales	$	(9)	—	(19)	—	(13)	—	6	—
Foreign currency	Sales	—		—	(2)	—	(2)	5	1	7
Foreign currency	Cost of sales	42		3	60	9	24	(10)	38	(3)
Foreign currency	Other deductions, net	(91)		(12)	(108)	(23)

Net Investment Hedges
Euro denominated debt		$	16	—	16	—	(46)	25	(183)	(27)
Total		$	(42)	(9)	(53)	(14)	(37)	20	(138)	(23)

Regardless of whether derivatives and non-derivative financial instruments receive hedge accounting, the Company expects hedging gains or losses to be offset by losses or gains on the related underlying exposures. The amounts ultimately recognized will differ from those presented above for open positions, which remain subject to ongoing market price fluctuations until settlement. Derivatives receiving hedge accounting are highly effective and no amounts were excluded from the assessment of hedge effectiveness.

Fair Value Measurement – Valuations for all derivatives and the Company's long-term debt fall within Level 2 of the GAAP valuation hierarchy. As of June 30, 2024, the fair value of long-term debt was approximately $6.6 billion, which was lower than the carrying value by $1,012. The fair value of foreign currency contracts, which are reported in Other current assets and Accrued expenses, did not materially change since September 30, 2023. Commodity contracts related to discontinued operations and were novated to Copeland upon the completion of the transaction.

Counterparties to derivatives arrangements are companies with investment-grade credit ratings. The Company has bilateral collateral arrangements with counterparties with credit rating-based posting thresholds that vary depending on the arrangement. If credit ratings on the Company's debt fall below pre-established levels, counterparties can require immediate full collateralization of all derivatives in net liability positions. The maximum amount that could potentially have been required was immaterial. The Company also can demand full collateralization of derivatives in net asset positions should any counterparty credit ratings fall below certain thresholds. No collateral was posted with counterparties and none was held by the Company as of June 30, 2024.

(13) ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)


Activity in Accumulated other comprehensive income (loss) for the three and nine months ended June 30, 2023 and 2024 is shown below, net of income taxes:
	Three Months Ended June 30,				Nine Months Ended June 30,
		2023		2024		2023	2024
Foreign currency translation
Beginning balance		$	(918)	(834)		(1,265)	(1,012)
Other comprehensive income (loss), net of tax of $3, $(6), $35 and $6, respectively		(10)		(122)		337	33
Reclassification to loss on divestiture of business		95		—		95	23
Ending balance		(833)		(956)		(833)	(956)

Pension and postretirement
Beginning balance		(255)		(271)		(222)	(247)
Amortization of deferred actuarial losses into earnings, net of tax of $6, $2, $13 and $6, respectively		(12)		(12)		(45)	(36)
Reclassified to gain on sale of business		22		—		22	—
Ending balance		(245)		(283)		(245)	(283)

Cash flow hedges
Beginning balance		25		8		2	6
Gains deferred during the period, net of taxes of $(2), $1, $(11) and $(1), respectively		7		(4)		34	3
Reclassification of realized (gains) losses to sales and cost of sales, net of tax of $1, $1, $3 and $2, respectively		(7)		(2)		(11)	(7)
Reclassified to gain on sale of business		(19)		—		(19)	—

Ending balance		6		2		6	2

Accumulated other comprehensive income (loss)		$	(1,072)	(1,237)		(1,072)	(1,237)

(14) BUSINESS SEGMENTS

As disclosed in Note 4, the Company completed the acquisition of NI on October 11, 2023. NI is now referred to as Test & Measurement and reported as a new segment in the Software and Control business group.

Summarized information about the Company's results of operations by business segment follows:


	Three Months Ended June 30,					Nine Months Ended June 30,
	Sales			Earnings (Loss)		Sales		Earnings (Loss)
	2023		2024	2023	2024	2023	2024	2023	2024

Final Control	$	1,035	1,046	245	253	2,889	3,037	618	706
Measurement & Analytical	913		982	257	252	2,550	2,942	661	761
Discrete Automation	668		618	124	109	1,969	1,863	378	322
Safety & Productivity	363		351	82	79	1,034	1,038	228	230
Intelligent Devices	2,979		2,997	708	693	8,442	8,880	1,885	2,019

Control Systems & Software	663		700	144	168	1,892	2,062	378	468
Test & Measurement	—		355	—	(88)	—	1,104	—	(245)
AspenTech	320		343	27	49	793	878	(60)	6
Software and Control	983		1,398	171	129	2,685	4,044	318	229

Stock compensation				(56)	(56)			(198)	(203)
Unallocated pension and postretirement costs				42	38			133	107
Corporate and other				(43)	(38)			(154)	(540)
Loss on Copeland note receivable				—	(279)			—	(279)
Gain on subordinated interest				—	—			—	79
Eliminations/Interest	(16)		(15)	(10)	(56)	(52)	(51)	(111)	(157)
Interest income from related party				10	24			10	86
Total	$	3,946	4,380	822	455	11,075	12,873	1,883	1,341

Stock compensation for the three months and nine months ended June 30, 2024 included $9 and $53 of integration-related stock compensation expense attributable to NI (of which $5 and $41, respectively, was reported as restructuring costs). Corporate and other for the three and nine months ended June 30, 2024 included acquisition/divestiture fees and related costs of $13 and $159, respectively, while year-to-date also includes acquisition-related inventory step-up amortization of $231 and a divestiture loss of $39. Corporate and other for the three and nine months ended June 30, 2023 included acquisition/divestiture costs of $38 and $48, respectively, and a mark-to-market gain of $12 and $47, respectively, related to its equity investment in National Instruments Corporation, while year-to-date also included a loss of $47 related to the Company's exit of business operations in Russia.

Depreciation and amortization (includes intellectual property, customer relationships and capitalized software) by business segment are summarized below:


	Three Months Ended June 30,				Nine Months Ended June 30,
		2023		2024		2023	2024
Final Control		$	39	41		129	120
Measurement & Analytical		26		32		84	105
Discrete Automation		20		22		63	65
Safety & Productivity		15		14		44	43
Intelligent Devices		100		109		320	333

Control Systems & Software		22		26		67	75
Test & Measurement		—		150		—	454
AspenTech		123		122		369	369
Software and Control		145		298		436	898

Corporate and other		12		10		24	32
Total		$	257	417		780	1,263

Test & Measurement depreciation and amortization for the three and nine months ended June 30, 2024 included intangibles amortization of $139 and $419 due to the acquisition.

Sales by geographic destination, Americas, Asia, Middle East & Africa ("AMEA") and Europe, are summarized below:


	Three Months Ended June 30,						Three Months Ended June 30,
	2023						2024
		Americas		AMEA	Europe	Total	Americas	AMEA	Europe	Total
Final Control		$	498	399	138	1,035	509	398	139	1,046
Measurement & Analytical		482		303	128	913	488	345	149	982
Discrete Automation		312		180	176	668	294	154	170	618
Safety & Productivity		269		18	76	363	262	18	71	351
Intelligent Devices		1,561		900	518	2,979	1,553	915	529	2,997

Control Systems & Software		322		207	134	663	326	224	150	700
Test & Measurement		—		—	—	—	160	98	97	355
AspenTech		111		104	105	320	167	75	101	343
Software and Control		433		311	239	983	653	397	348	1,398


Total		$	1,994	1,211	757	3,962	2,206	1,312	877	4,395

	Nine Months Ended June 30,						Nine Months Ended June 30,
	2023						2024
		Americas		AMEA	Europe	Total	Americas	AMEA	Europe	Total
Final Control		$	1,438	1,069	382	2,889	1,476	1,172	389	3,037
Measurement & Analytical		1,333		853	364	2,550	1,475	1,004	463	2,942
Discrete Automation		914		539	516	1,969	874	477	512	1,863
Safety & Productivity		777		51	206	1,034	774	53	211	1,038
Intelligent Devices		4,462		2,512	1,468	8,442	4,599	2,706	1,575	8,880

Control Systems & Software		930		578	384	1,892	972	650	440	2,062
Test & Measurement		—		—	—	—	486	295	323	1,104
AspenTech		337		228	228	793	428	208	242	878
Software and Control		1,267		806	612	2,685	1,886	1,153	1,005	4,044


Total		$	5,729	3,318	2,080	11,127	6,485	3,859	2,580	12,924

Items 2 and 3.

Management's Discussion and Analysis of Financial Condition and Results of Operations

(Dollars are in millions, except per share amounts or where noted)

OVERVIEW

On October 11, 2023, the Company completed the acquisition of National Instruments Corporation (“NI”), which is now referred to as Test & Measurement and reported as a new segment in the Software and Control business group. NI provides software-connected automated test and measurement systems that enable enterprises to bring products to market faster and at a lower cost, and had revenues of approximately $1.7 billion for the 12 months ended September 30, 2023. See Note 4.

On June 6, 2024, the Company entered into definitive agreements to sell its 40 percent non-controlling common equity interest in Copeland to private equity funds managed by Blackstone for $1.5 billion and its note receivable to Copeland for $1.9 billion. Upon entering into the note agreement, the Company recorded a pretax loss of $279 ($217 after-tax, $0.38 per share) to adjust the carrying value of the note to $1.9 billion to reflect the transaction price. The equity method losses related to the Company's non-controlling common equity interest in Copeland, which were reported since May 2023 in Other deductions, net, have been reclassified and are now reported as discontinued operations for all periods presented. See Notes 5 and 10 for further detail.

For the third quarter of fiscal 2024, net sales were $4.4 billion, up 11 percent compared with the prior year. Underlying sales, which exclude foreign currency translation, acquisitions and divestitures, were up 3 percent. Foreign currency translation had a 1 percent unfavorable impact and the Test & Measurement acquisition added 9 percent.

Earnings from continuing operations attributable to common stockholders were $344, down 46 percent, and diluted earnings per share from continuing operations were $0.60, down 46 percent compared with $1.12 in the prior year. The decrease was largely due to the Company's definitive agreement to sell its Copeland note receivable for $1.9 billion, which resulted in a pretax loss of $279 ($217 after-tax, $0.38 per share) to adjust the carrying value of the note to reflect the transaction price (see Note 10 and further discussion below). Adjusted diluted earnings per share from continuing operations were $1.43, up 11 percent compared with $1.29 in the prior year, reflecting sales growth and strong operating performance, as well as a $0.09 contribution from Test & Measurement.

The table below presents the Company's diluted earnings per share from continuing operations on an adjusted basis to facilitate period-to-period comparisons and provide additional insight into the underlying, ongoing operating performance of the Company. Adjusted diluted earnings per share from continuing operations excludes intangibles amortization expense, restructuring expense, first year purchase accounting related items and transaction-related costs, and certain gains, losses or impairments.


Three Months Ended June 30,	2023		2024

Diluted earnings from continuing operations per share	$	1.12	0.60

Amortization of intangibles	0.15		0.35
Restructuring and related costs	0.02		0.08
Acquisition/divestiture fees and related costs	0.07		0.02



National Instruments investment gain	(0.02)		—
Interest income on undeployed proceeds from Copeland transaction	(0.05)		—

Loss on Copeland note receivable	—		0.38



Adjusted diluted earnings from continuing operations per share	$	1.29	1.43

The table below summarizes the changes in adjusted diluted earnings per share from continuing operations. The items identified below are discussed throughout MD&A, see further discussion above and in the Business Segments and Financial Position sections below.


	Three Months Ended
Adjusted diluted earnings from continuing operations per share - June 30, 2023	$	1.29

Operations	0.16
Foreign currency	0.01
Effective tax rate and other	(0.03)


Adjusted diluted earnings from continuing operations per share - June 30, 2024	$	1.43

RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30

Following is an analysis of the Company’s operating results for the third quarter ended June 30, 2023, compared with the third quarter ended June 30, 2024.


	2023			2024		Change
(dollars in millions, except per share amounts)

Net sales	$	3,946		4,380		11	%
Gross profit	$	1,994		2,314		16	%
Percent of sales	50.5		%	52.8	%	2.3 pts

SG&A	$	1,042		1,254		20	%
Percent of sales	26.4		%	28.6	%	2.2 pts




Loss on Copeland note receivable	$	—		279

Other deductions, net	$	130		294
Amortization of intangibles	$	120		264
Restructuring costs	$	12		57

Interest expense, net	$	10		56
Interest income from related party	$	(10)		(24)

Earnings from continuing operations before income taxes	$	822		455		(45)	%
Percent of sales	20.8		%	10.4	%	(10.4) pts
Earnings from continuing operations common stockholders	$	643		344		(46)	%
Percent of sales	16.3		%	7.9	%	(8.4) pts
Net earnings common stockholders	$	9,352		329		(96)	%


Diluted EPS - Earnings from continuing operations	$	1.12		0.60		(46)	%
Diluted EPS - Net earnings	$	16.28		0.57		(96)	%

Adjusted Diluted EPS - Earnings from continuing operations	$	1.29		1.43		11	%

Net sales for the third quarter of fiscal 2024 were $4.4 billion, up 11 percent compared with 2023. Intelligent Devices sales were up 1 percent, while Software and Control sales were up 42 percent, which included the impact of the Test & Measurement acquisition. Underlying sales were up 3 percent on 1 percent higher volume and 2 percent higher price. Foreign currency translation had a 1 percent unfavorable impact and the Test & Measurement acquisition added 9 percent. Underlying sales were down 2 percent in the U.S. and up 7 percent internationally. The Americas was up 3 percent, Europe was up 4 percent, and Asia, Middle East & Africa was up 2 percent (China down 11 percent).

Cost of sales for the third quarter of fiscal 2024 were $2,066, an increase of $114 compared with 2023, reflecting the impact of higher volume and the Test & Measurement acquisition. Gross margin of 52.8 percent increased 2.3 percentage points, reflecting the Test & Measurement acquisition and higher price, partially offset by unfavorable geographic mix in Intelligent Devices.

Selling, general and administrative (SG&A) expenses of $1,254 increased $212 and SG&A as a percent of sales increased 2.2 percentage points to 28.6 percent compared with the prior year, reflecting the impact of the Test & Measurement acquisition.

As discussed above, upon entering into the agreement to sell the Copeland note receivable, the Company recorded a pretax loss of $279 ($217 after-tax, $0.38 per share) to adjust the carrying value of the note to $1.9 billion to reflect the transaction price.

Other deductions, net were $294 for the third quarter of fiscal 2024, an increase of $164 compared with the prior year. The current year included intangibles amortization related to the Test & Measurement acquisition of $139 and restructuring costs of $57. The prior year included acquisition/divestiture costs of $38, a mark-to-market gain of $12 related to the Company's equity investment in National Instruments Corporation and a mark-to-market gain of $3 related to foreign currency forward contracts that were terminated in June 2023. See Note 7 and Note 10.

Pretax earnings from continuing operations of $455 decreased $367, down 45 percent compared with the prior year. Earnings decreased $15 in Intelligent Devices and decreased $42 in Software and Control. See the Business Segments discussion that follows and Note 14.

Earnings from continuing operations attributable to common stockholders were $344, down 46 percent, and diluted earnings per share from continuing operations were $0.60, down 46 percent compared with $1.12 in the prior year. Adjusted diluted earnings per share from continuing operations were $1.43 compared with $1.29 in the prior year, up 11 percent, reflecting strong operating results. See the analysis above of adjusted earnings per share for further details.

Earnings (Loss) from discontinued operations were ($15) ($(0.03) per share) for the third quarter of fiscal 2024 and $8,709 ($15.16 per share) in the prior year. See Note 5.

Net earnings common stockholders in the third quarter of fiscal 2024 were $329 compared with $9,352 in the prior year, and earnings per share were $0.57 compared with $16.28 in the prior year.

The table below, which shows results from continuing operations on an adjusted EBITA basis, is intended to supplement the Company's discussion of its results of operations herein. The Company defines adjusted EBITA as earnings from continuing operations excluding interest expense, net, income taxes, intangibles amortization expense, restructuring expense, first year purchase accounting related items and transaction-related costs, and certain gains, losses or impairments. Adjusted EBITA and adjusted EBITA margin are measures used by management and may be useful for investors to evaluate the Company's operational performance.


Three Months Ended June 30,	2023			2024		Change

Earnings from continuing operations before income taxes	$	822		455		(45)	%
Percent of sales	20.8		%	10.4	%	(10.4) pts
Interest expense, net	10			56
Interest income from related party	(10)			(24)
Amortization of intangibles	169			313
Restructuring and related costs	13			60
Acquisition/divestiture fees and related costs	38			17


National Instruments investment gain	(12)			—
AspenTech Micromine purchase price hedge	(3)			—

Loss on Copeland note receivable	—			279


Adjusted EBITA from continuing operations	$	1,027		1,156		13	%
Percent of sales	26.0		%	26.4	%	0.4 pts

Business Segments

Following is an analysis of operating results for the Company’s business segments for the third quarter ended June 30, 2023, compared with the third quarter ended June 30, 2024. The Company defines segment earnings as earnings before interest and taxes. See Note 14 for a discussion of the Company's business segments.

INTELLIGENT DEVICES


	2023			2024		Change		FX		Acq/Div		U/L


Sales:
Final Control	$	1,035		1,046		1	%	1	%	—	%	2	%
Measurement & Analytical	913			982		8	%	1	%	—	%	9	%
Discrete Automation	668			618		(8)	%	2	%	—	%	(6)	%
Safety & Productivity	363			351		(3)	%	—	%	—	%	(3)	%
Total	$	2,979		2,997		1	%	1	%	—	%	2	%

Earnings:
Final Control	$	245		253		3	%
Measurement & Analytical	257			252		(2)	%
Discrete Automation	124			109		(12)	%
Safety & Productivity	82			79		(4)	%
Total	$	708		693		(2)	%
Margin	23.7		%	23.1	%	(0.6) pts

Amortization of intangibles:
Final Control	$	22		21
Measurement & Analytical	5			11
Discrete Automation	8			9
Safety & Productivity	7			6
Total	$	42		47

Restructuring and related costs:
Final Control	$	(1)		5
Measurement & Analytical	1			3
Discrete Automation	12			16
Safety & Productivity	(1)			1
Total	$	11		25

Adjusted EBITA	$	761		765		1	%
Adjusted EBITA Margin	25.5		%	25.5	%	- pts

Intelligent Devices sales were $3.0 billion in the third quarter of 2024, an increase of $18, or 1 percent. Underlying sales increased 2 percent on higher price. Underlying sales were flat in the Americas, Europe increased 3 percent and Asia, Middle East & Africa was up 4 percent (China down 9 percent). Final Control sales increased $11, or 1 percent, reflecting strength in energy and power end markets, particularly in Latin America and Middle East & Africa, largely offset by declines in the U.S. and China. Sales for Measurement & Analytical increased $69, or 8 percent, reflecting strong growth in nearly all geographies and strong backlog conversion. Discrete Automation sales decreased $50, or 8 percent, reflecting weakness across most geographies driven in part by lower factory automation demand. Safety & Productivity sales decreased $12, or 3 percent, due to softness across all geographies. Earnings for Intelligent Devices were $693, a decrease of $15, or 2 percent, and margin decreased 0.6 percentage points to 23.1 percent, reflecting higher restructuring costs. Adjusted EBITA margin was 25.5 percent, flat compared with the prior year, reflecting favorable price less net material inflation, partially offset by unfavorable geographic mix, softer MRO and increases in other costs.

SOFTWARE AND CONTROL


	2023			2024		Change		FX		Acq/Div		U/L


Sales:
Control Systems & Software	$	663		700		6	%	1	%	—	%	7	%
Test & Measurement	—			355		—	%
AspenTech	320			343		7	%	—	%	—	%	7	%
Total	$	983		1,398		42	%	1	%	(36)	%	7	%

Earnings:
Control Systems & Software	$	144		168		16	%
Test & Measurement	—			(88)		—	%
AspenTech	27			49		90	%
Total	$	171		129		(24)	%
Margin	17.4		%	9.2	%	(8.2) pts

Amortization of intangibles:
Control Systems & Software	$	6		6
Test & Measurement	—			139
AspenTech	121			121
Total	$	127		266

Restructuring and related costs:
Control Systems & Software	$	1		4
Test & Measurement	—			25
AspenTech	—			—
Total	$	1		29

Adjusted EBITA	$	299		424		42	%
Adjusted EBITA Margin	30.4		%	30.3	%	(0.1) pts

Software and Control sales were $1.4 billion in the third quarter of 2024, an increase of $415, or 42 percent compared to the prior year, reflecting the impact of the Test & Measurement acquisition and strong growth in Control Systems & Software and AspenTech. Underlying sales were up 7 percent on 5 percent higher volume and 2 percent higher price. Underlying sales increased 15 percent in the Americas and 6 percent in Europe, while Asia, Middle East & Africa decreased 3 percent (China down 20 percent). Control Systems & Software sales increased $37, or 6 percent, reflecting strong international demand in process and hybrid end markets and strong demand in power end markets in the Americas. Test & Measurement sales were $355 for the third quarter. AspenTech sales increased $23, or 7 percent, reflecting higher license, maintenance and services revenue. Earnings for Software and Control decreased $42, down 24 percent, and margin decreased 8.2 percentage points due to the Test & Measurement loss which reflected significant intangibles amortization and restructuring. Adjusted EBITA margin decreased 0.1 percentage points, reflecting the impact of the Test & Measurement acquisition, largely offset by leverage on higher sales and higher price.

RESULTS OF OPERATIONS FOR THE NINE MONTHS ENDED JUNE 30

Following is an analysis of the Company’s operating results for the nine months ended June 30, 2023, compared with the nine months ended June 30, 2024.


	2023			2024		Change
(dollars in millions, except per share amounts)

Net sales	$	11,075		12,873		16	%
Gross profit	$	5,415		6,514		20	%
Percent of sales	48.9		%	50.6	%	1.7 pts

SG&A	$	3,072		3,827		25	%
Percent of sales	27.7		%	29.7	%	2.0 pts

Loss on Copeland note receivable	$	—		279
Gain on subordinated interest	$	—		(79)
Other deductions, net	$	359		1,075
Amortization of intangibles	$	357		811
Restructuring costs	$	41		170

Interest expense, net	$	111		157
Interest income from related party	$	(10)		(86)

Earnings from continuing operations before income taxes	$	1,883		1,341		(29)	%
Percent of sales	17.0		%	10.4	%	(6.6) pts
Earnings from continuing operations common stockholders	$	1,502		1,060		(30)	%
Percent of sales	13.6		%	8.2	%	(5.4) pts
Net earnings common stockholders	$	12,475		972		(92)	%

Diluted EPS - Earnings from continuing operations	$	2.60		1.84		(29)	%
Diluted EPS - Net earnings	$	21.56		1.69		(92)	%

Adjusted Diluted EPS - Earnings from continuing operations	$	3.15		4.01		27	%

Net sales for the first nine months of 2024 were $12.9 billion, up 16 percent compared with 2023. Intelligent Devices sales were up 5 percent, while Software and Control sales were up 51 percent, which included the impact of the Test & Measurement acquisition. Underlying sales were up 7 percent on 5 percent higher volume and 2 percent higher price. Foreign currency translation had a 0.5 percent unfavorable impact, the Test & Measurement acquisition added 10 percent and the divestiture of Metran deducted 0.5 percent. Underlying sales increased 3 percent in the U.S. and increased 10 percent internationally. The Americas was up 5 percent, Europe was up 9 percent and Asia, Middle East & Africa was up 9 percent (China was down 2 percent).

Cost of sales for 2024 were $6,359, an increase of $699 versus $5,660 in 2023, reflecting the impact of higher volume and the Test & Measurement acquisition. Gross margin of 50.6 percent increased 1.7 percentage points, reflecting the Test & Measurement acquisition, higher price and leverage on higher sales, partially offset by the impact from acquisition-related inventory step-up amortization of $231, which negatively impacted margins by approximately 1.8 percentage points.

SG&A expenses of $3,827 increased $755 and SG&A as a percent of sales increased 2.0 percentage points to 29.7 percent, reflecting the impact of the Test & Measurement acquisition, partially offset by strong operating leverage on higher sales and mix.

On June 6, 2024, the Company entered into definitive agreements to sell its 40 percent non-controlling common equity interest in Copeland to private equity funds managed by Blackstone for $1.5 billion and its note receivable to Copeland for $1.9 billion. Upon entering into the note agreement, the Company recorded a pretax loss of $279 ($217 after-tax, $0.38 per share) to adjust the carrying value of the note to $1.9 billion to reflect the transaction price. The equity method losses related to the Company's non-controlling common equity interest in Copeland, which were reported since May 2023 in Other deductions, net, have been reclassified and are now reported as discontinued operations for all periods presented. See Notes 5 and 10 for further detail.

In the second quarter of fiscal 2024, the Company received its final distribution of $79 related to its subordinated interest in Vertiv.

Other deductions, net were $1,075 in 2024, an increase of $716 compared with the prior year. The current year included intangibles amortization related to the Test & Measurement acquisition of $419, restructuring costs of $170, acquisition/divestiture costs of $92, and a divestiture loss of $39. The prior year included a charge of $47 related to the Company exiting its business in Russia, acquisition/divestiture costs of $48, a mark-to-market gain of $47 related to the Company's equity investment in National Instruments Corporation and a mark-to-market gain of $24 related to foreign currency forward contracts that were terminated in June 2023. See Note 7 and Note 10.

Pretax earnings from continuing operations of $1,341 decreased $542 compared with prior year. Earnings increased $134 in Intelligent Devices and decreased $89 in Software and Control. See the Business Segments discussion that follows and Note 14.

Income taxes were $266 in the first nine of months of fiscal 2024 and $400 in 2023, resulting in effective tax rates of 20 percent and 21 percent, respectively. The current year rate included a $57 ($0.10 per share) benefit related to discrete tax items and a benefit related to the filing of the prior year U.S. tax return, partially offset by unfavorable impacts from inventory step-up amortization and the loss on divestiture (see Note 4), which was nondeductible for tax purposes. In total, the net impact of these items benefited the rate by approximately 2 percentage points, which was partially offset by other items.

Earnings from continuing operations attributable to common stockholders were $1,060, down 30 percent compared with the prior year, and diluted earnings per share from continuing operations were $1.84, down 29 percent compared with $2.60 in 2023. Adjusted diluted earnings per share from continuing operations were $4.01 compared with $3.15 in the prior year, up 27 percent. See the analysis below of adjusted earnings per share for further details.

Earnings (Loss) from discontinued operations were $(88) ($(0.15) per share), compared with $10,973 ($19.06 per share) in the prior year, reflecting the $8.4 billion after-tax gain on the Copeland transaction and the $2.1 billion after-tax gain on the InSinkErator divestiture. See Note 5.

Net earnings common stockholders were $972 ($1.69 per share) compared with $12,475 ($21.56 per share) in the prior year.

The table below presents the Company's diluted earnings per share on an adjusted basis to facilitate period-to-period comparisons and provide additional insight into the underlying, ongoing operating performance of the Company.


Nine Months Ended June 30,	2023		2024

Diluted earnings from continuing operations per share	$	2.60	1.84

Amortization of intangibles	0.46		1.07
Restructuring and related costs	0.07		0.25
Discrete taxes	—		(0.10)
Amortization of acquisition-related inventory step-up	—		0.38
Acquisition/divestiture fees and related costs	0.07		0.22
Loss on divestiture of business	—		0.07
Gain on subordinated interest	—		(0.10)
National Instruments investment gain	(0.06)		—
AspenTech Micromine purchase price hedge	(0.02)		—
Interest income on undeployed proceeds from Copeland transaction	(0.05)		—
Loss on Copeland note receivable	—		0.38
Russia business exit charge	0.08		—

Adjusted diluted earnings from continuing operations per share	$	3.15	4.01

The table below summarizes the changes in adjusted diluted earnings per share. The items identified below are discussed throughout MD&A, see further discussion above and in the Business Segments and Financial Position sections below.


	Nine Months Ended
Adjusted diluted earnings from continuing operations per share - June 30, 2023	$	3.15

Operations	0.79

Stock compensation	0.05
Foreign currency	(0.01)
Pensions	(0.02)
Effective tax rate	(0.04)
Interest income from related party	0.08
Share count	0.01


Adjusted diluted earnings from continuing operations per share - June 30, 2024	$	4.01

The table below, which shows results on an adjusted EBITA basis, is intended to supplement the Company's discussion of its results of operations herein.


Nine Months Ended June 30,	2023			2024		Change

Earnings from continuing operations before income taxes	$	1,883		1,341		(29)	%
Percent of sales	17.0		%	10.4	%	(6.6) pts
Interest expense, net	111			157
Interest income from related party	(10)			(86)
Amortization of intangibles	504			958
Restructuring and related costs	54			180
Acquisition/divestiture fees and related costs	48			171
Loss on divestiture of business	—			39
Amortization of acquisition-related inventory step-up	—			231
Gain on subordinated interest	—			(79)
National Instruments investment gain	(47)			—
AspenTech Micromine purchase price hedge	(24)			—
Loss on Copeland note receivable	—			279
Russia business exit charge	47			—
Adjusted EBITA from continuing operations	$	2,566		3,191		24	%
Percent of sales	23.2		%	24.8	%	1.6 pts

Business Segments

Following is an analysis of operating results for the Company’s business segments for the nine months ended June 30, 2023, compared with the nine months ended June 30, 2024. The Company defines segment earnings as earnings before interest and taxes. As a result of the Company's portfolio transformation, the Company has realigned its business segments and now reports six segments and two business groups. See Note 14.

INTELLIGENT DEVICES


	2023			2024		Change		FX		Acq/Div		U/L


Sales:
Final Control	$	2,889		3,037		5	%	1	%	—	%	6	%
Measurement & Analytical	2,550			2,942		15	%	1	%	1	%	17	%
Discrete Automation	1,969			1,863		(5)	%	—	%	—	%	(5)	%
Safety & Productivity	1,034			1,038		—	%	—	%	—	%	—	%
Total	$	8,442		8,880		5	%	1	%	—	%	6	%

Earnings:
Final Control	$	618		706		14	%
Measurement & Analytical	661			761		15	%
Discrete Automation	378			322		(15)	%
Safety & Productivity	228			230		1	%
Total	$	1,885		2,019		7	%
Margin	22.3		%	22.7	%	0.4 pts

Amortization of intangibles:
Final Control	$	66		65
Measurement & Analytical	15			43
Discrete Automation	22			26
Safety & Productivity	20			19
Total	$	123		153

Restructuring and related costs:
Final Control	$	12		5
Measurement & Analytical	2			7
Discrete Automation	20			33
Safety & Productivity	1			2
Total	$	35		47


Adjusted EBITA	$	2,043		2,219		9	%
Adjusted EBITA Margin	24.2		%	25.0	%	0.8 pts

Intelligent Devices sales were $8.9 billion in the first nine months of 2024, an increase of $438, or 5 percent. Underlying sales increased 6 percent on 4 percent higher volume and 2 percent higher price. Underlying sales increased 3 percent in the Americas, Europe increased 8 percent, and Asia, Middle East & Africa was up 10 percent (China down 2 percent). Final Control sales increased $148, or 5 percent, reflecting strength in energy and power end markets. Sales for Measurement & Analytical increased $392, or 15 percent, reflecting robust growth in all geographies and strong backlog conversion. Discrete Automation sales decreased $106, or 5 percent, reflecting softness in all geographies. Safety & Productivity sales increased $4, essentially flat, reflecting moderate results across all geographies. Earnings for Intelligent Devices were $2,019, an increase of $134, or 7 percent, and margin increased 0.4 percentage points to 22.7 percent. Adjusted EBITA margin was 25.0 percent, an increase of 0.8 percentage points, reflecting leverage on higher sales and favorable price less net material inflation, partially offset by increases in other costs.

SOFTWARE AND CONTROL


	2023			2024		Change		FX		Acq/Div		U/L


Sales:
Control Systems & Software	$	1,892		2,062		9	%	—	%	1	%	10	%
Test & Measurement	—			1,104		—	%
AspenTech	793			878		11	%	—	%	—	%	11	%
Total	$	2,685		4,044		51	%	—	%	(41)	%	10	%

Earnings:
Control Systems & Software	$	378		468		24	%
Test & Measurement	—			(245)		—	%
AspenTech	(60)			6		110	%
Total	$	318		229		(28)	%
Margin	11.8		%	5.7	%	(6.1) pts

Amortization of intangibles:
Control Systems & Software	$	17		22
Test & Measurement	—			419
AspenTech	364			364
Total	$	381		805

Restructuring and related costs:
Control Systems & Software	$	7		8
Test & Measurement	—			81
AspenTech	—			—
Total	$	7		89

Adjusted EBITA	$	706		1,123		59	%
Adjusted EBITA Margin	26.3		%	27.8	%	1.5 pts

Software and Control sales were $4,044 in the first nine months of 2024,an increase of $1,359, or 51 percent compared to the prior year, reflecting the impact of the Test & Measurement acquisition. Underlying sales were up 10 percent on 8 percent higher volume and 2 percent higher price. Underlying sales increased 11 percent in the Americas, 12 percent in Europe and 8 percent in Asia, Middle East & Africa (China down 3 percent). Control Systems & Software sales increased $170, or 9 percent, reflecting strong international demand in process and hybrid end markets while power end markets were strong globally. Test & Measurement sales were $1,104 in the first nine months of 2024. AspenTech sales increased $85, or 11 percent, reflecting higher license, maintenance and services revenue. Earnings for Software and Control decreased $89, down 28 percent, and margin decreased 6.1 percentage points, reflecting the impact from $419 of incremental intangibles amortization related to the Test & Measurement acquisition. Adjusted EBITA margin increased 1.5 percentage points, reflecting leverage on higher sales and higher price, partially offset by the impact of the Test & Measurement acquisition.

FINANCIAL CONDITION

Key elements of the Company's financial condition as of and for the nine months ended June 30, 2024 as compared to the year ended September 30, 2023 and the nine months ended June 30, 2023 follow.


	June 30, 2023			Sept 30, 2023			June 30, 2024
Operating working capital	$	(144)		$	1,283		$	1,921
Current ratio	2.4			2.7			1.2
Total debt-to-total capital	28.9		%	28.3		%	32.7		%
Net debt-to-net capital	(8.8)		%	0.5		%	27.3		%
Interest coverage ratio	10.1		X	12.1		X	6.1		X

Operating working capital increased due to the acquisition of NI. As of June 30, 2024, Emerson's cash and equivalents totaled $2,298, which included approximately $240 attributable to AspenTech. The cash held by AspenTech is intended to be used for its own purposes and is not available to return to Emerson shareholders.

The current ratio decreased compared to September 30, 2023, reflecting the decrease in cash and increase in short-term borrowings used to support the NI acquisition. The interest coverage ratio (earnings before income taxes plus interest expense, divided by interest expense) of 6.1X for the first nine months of fiscal 2024 compares to 10.1X for the nine months ended June 30, 2023, reflecting lower GAAP pretax earnings largely due to the NI acquisition. Excluding the impact from acquisition-related inventory step-up amortization of $231, higher intangibles amortization of $454, acquisition/divestiture fees and related costs of $171, higher restructuring and related costs of $127, the loss of $279 on the Copeland note receivable and the gain on subordinated interest of $79, the interest coverage ratio was 10.7X.

Operating cash flow from continuing operations for the first nine months of fiscal 2024 was $2,244, an increase of $525 compared with $1,719 in the prior year, reflecting higher earnings (excluding the impact of items related to the NI acquisition and the loss on the Copeland note receivable) and favorable changes in working capital. Acquisition-related costs and integration activities negatively impacted operating cash flow in the current year by approximately $210. AspenTech generated operating cash flow of approximately $320 compared to approximately $295 in the prior year. Free cash flow from continuing operations of $1,993 in the first nine months of fiscal 2024 (operating cash flow of $2,244 less capital expenditures of $251) increased $468 compared to free cash flow of $1,525 in 2023 (operating cash flow of $1,719 less capital expenditures of $194), reflecting the increase in operating cash flow, partially offset by higher capital expenditures. Cash used in investing activities from continuing operations was $8,600, reflecting the acquisition of NI. Cash provided by financing activities from continuing operations was $583, reflecting an increase in short-term borrowings of $2,229, partially offset by the repayment of €500 of euro-denominated debt that was due in May 2024, share repurchases and dividends.

Total cash provided by operating activities was $2,248 including the impact of discontinued operations, and increased $968 compared with $1,280 in the prior year.

Subsequent to the end of the quarter, the Company completed the sale of its note receivable to Copeland on August 2, 2024 and received $1.9 billion of pretax cash proceeds. The Company expects the sale of its 40 percent non-controlling common equity interest in Copeland to private equity funds managed by Blackstone for $1.5 billion to close by the end of August 2024. The Company intends to use the approximately $2.9 billion of after-tax cash proceeds from both transactions to pay down its existing debt obligations.

Emerson maintains a conservative financial structure to provide the strength and flexibility necessary to achieve our strategic objectives and has been successful in efficiently deploying cash where needed worldwide to fund operations, complete acquisitions and sustain long-term growth. Emerson is in a strong financial position, with total assets of $46 billion and common stockholders' equity of $21 billion, and has the resources available for reinvestment in existing businesses, strategic acquisitions and managing its capital structure on a short- and long-term basis.

FISCAL 2024 OUTLOOK

For the full year, consolidated net sales from continuing operations are expected to be up approximately 15 percent, with underlying sales up approximately 6 percent excluding an approximate 9.5 percent impact from the NI acquisition and a 0.5 percent unfavorable impact from foreign currency. Earnings per share from continuing operations are expected to be $2.82 to $2.87, while adjusted earnings per share from continuing operations are expected to be $5.45 to $5.50 (see the following reconciliation).


Outlook for Fiscal 2024 Earnings Per Share						2024

Diluted earnings from continuing operations per share						$2.82 - $2.87

Amortization of intangibles						~ 1.42
Restructuring and related costs						~ 0.34
Loss on Copeland note receivable						0.38
Amortization of acquisition-related inventory step-up						0.38
Acquisition/divestiture fees and related costs						~ 0.24
Divestiture loss / (gain), net						(0.03)
Discrete tax benefits						(0.10)

Adjusted diluted earnings from continuing operations per share						$5.45- $5.50

Operating cash flow from continuing operations is expected to be approximately $3.2 billion and free cash flow from continuing operations, which excludes projected capital spending of approximately $0.4 billion, is expected to be approximately $2.8 billion. The fiscal 2024 outlook assumes approximately $300 million returned to shareholders through share repurchases and approximately $1.2 billion of dividend payments.

Statements in this report that are not strictly historical may be "forward-looking" statements, which involve risks and uncertainties, and Emerson undertakes no obligation to update any such statements to reflect later developments. These risks and uncertainties include the scope, duration and ultimate impacts of the Russia-Ukraine and other global conflicts, as well as economic and currency conditions, market demand, pricing, protection of intellectual property, cybersecurity, tariffs, competitive and technological factors, and inflation, among others, which are set forth in the “Risk Factors” of Part I, Item 1A, and the "Safe Harbor Statement" of Part II, Item 7, to the Company's Annual Report on Form 10-K for the year ended September 30, 2023 and in subsequent reports filed with the SEC, which are hereby incorporated by reference.

Item 4. Controls and Procedures

The Company maintains a system of disclosure controls and procedures designed to ensure that information required to be disclosed in its reports under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported in a timely manner. This system also is designed to ensure information is accumulated and communicated to management, including the Company's certifying officers, to allow timely decisions regarding required disclosure. Based on an evaluation performed, the certifying officers have concluded that the disclosure controls and procedures were effective as of the end of the period covered by this report.

Notwithstanding the foregoing, there can be no assurance that the Company's disclosure controls and procedures will detect or uncover all failures of persons within the Company and its consolidated subsidiaries to report material information otherwise required to be set forth in the Company's reports.

There was no change in the Company's internal control over financial reporting during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting.

PART II. OTHER INFORMATION

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Neither the Company nor any “affiliated purchaser” repurchased any shares of Company common stock during the three-month period ended June 30, 2024. In March 2020, the Board of Directors authorized the purchase of 60 million shares and a total of approximately 31.4 shares remain available for purchase under the authorization.

Item 5. Other Information

During the three-month period ended June 30, 2024, none of our directors or officers adopted or terminated a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement.

Item 6. Exhibits

(a) Exhibits (Listed by numbers corresponding to the Exhibit Table of Item 601 in Regulation S-K).





















2.1*			Note Purchase Agreement, dated as of June 6, 2024, among Emerson Electric Co., EMR Holdings, Inc., Emerald JV Holdings L.P., and EMRLD Seller Notes Issuer LP, incorporated by reference to the Company’s Form 8-K filed on June 6, 2024, File No. 1-278, Exhibit 2.1.

2.2*			Unit Purchase Agreement, dated as of June 6, 2024, among Emersub 21 LLC, Emersub 22 LLC, Humboldt Hermetic Motor Corp., Emersub XLVI, Inc., BCP Emerald Aggregator L.P., Emerald JV Holdings L.P., and Emerald JV Holdings G.P. LLC, incorporated by reference to the Company’s Form 8-K filed on June 6, 2024, File No. 1-278, Exhibit 2.2.

31			Certifications pursuant to Exchange Act Rule 13a-14(a).

32			Certifications pursuant to Exchange Act Rule 13a-14(b) and 18 U.S.C. Section 1350.

101			Attached as Exhibit 101 to this report are the following documents formatted in iXBRL (Inline Extensible Business Reporting Language): (i) Consolidated Statements of Earnings for the three and nine months ended June 30, 2024 and 2023, (ii) Consolidated Statements of Comprehensive Income for the three and nine months ended June 30, 2024 and 2023, (iii) Consolidated Balance Sheets as of September 30, 2023 and June 30, 2024, (iv) Consolidated Statements of Equity for the three and nine months ended June 30, 2024 and 2023, (v) Consolidated Statements of Cash Flows for the nine months ended June 30, 2024 and 2023, and (vi) Notes to Consolidated Financial Statements for the three and nine months ended June 30, 2024 and 2023.

104			Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

			* Certain schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. Emerson agrees to furnish supplementally a copy of any omitted schedule or exhibit to the SEC upon request.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

EMERSON ELECTRIC CO.

/s/ M. J. Baughman

M. J. Baughman

Executive Vice President, Chief Financial Officer

and Chief Accounting Officer

(on behalf of the registrant and as Chief Financial Officer)

August 7, 2024

Get the next $EMR alert in real time by email

Date	Price Target	Rating	Analyst
2/5/2026	$170.00	Buy → Hold	Deutsche Bank
1/27/2026		Outperform → Perform	Oppenheimer
1/9/2026	$150.00	Buy → Hold	TD Cowen
1/5/2026	$168.00	Neutral → Buy	UBS
12/15/2025	$170.00	Outperform	Evercore ISI
12/10/2025	$145.00	Buy → Hold	Jefferies
10/6/2025	$140.00	Overweight → Equal Weight	Wells Fargo
8/7/2025	$127.00	Underweight → Equal Weight	Barclays

SEC Form 10-Q filed by Emerson Electric Company

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$EMR

$EMR
Insider Trading

Director Levatich Matthew S sold $239,349 worth of shares (1,476 units at $162.16), decreasing direct ownership by 6% to 24,349 units (SEC Form 4)

Executive Vice Pres & COO Krishnan Ram R. covered exercise/tax liability with 5,319 shares, decreasing direct ownership by 8% to 60,046 units (SEC Form 4)

Senior VP & CPO Piazza Nicholas J. sold $1,066,245 worth of shares (6,703 units at $159.07), decreasing direct ownership by 17% to 31,664 units (SEC Form 4)

$EMR
Analyst Ratings

Emerson downgraded by Deutsche Bank with a new price target

Emerson downgraded by Oppenheimer

Emerson downgraded by TD Cowen with a new price target

$EMR
SEC Filings

Emerson Electric Company filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders